Inventor · disambiguated record
James Heyes
Also filed as: HEYES JAMES
32 granted patents·41 pending applications·2,880 citations·filing 1974–2025
98Inventor score
Files withARBUTUS BIOPHARMA CORP24PROTIVA BIOTHERAPEUTICS INC18GENEVANT SCIENCES GMBH12HEYES JAMES7MACLACHLAN IAN3
Top patents by PatentIndex Score
73 records- 0199US7799565B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Sep 21, 2010·367 cites·26 claims
- 0299US7745651B2Cationic lipids and methods of usePROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Jun 29, 2010·368 cites·4 claims
- 0398US12016929B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Jun 25, 2024·5 cites·22 claims
- 0498US11786598B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Oct 17, 2023·7 cites·17 claims
- 0598US9878042B2Lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·23 cites·18 claims
- 0698US9018187B2Cationic lipids and methods for the delivery of therapeutic agentsPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·116 cites·33 claims
- 0798US8283333B2Lipid formulations for nucleic acid deliveryYAWORSKI ED·Filed 2010·Granted Oct 9, 2012·313 cites·39 claims
- 0898US7982027B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Granted Jul 19, 2011·228 cites·63 claims
- 0998US7803397B2Polyethyleneglycol-modified lipid compounds and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 28, 2010·313 cites·15 claims
- 1097US9352042B2Trialkyl cationic lipids and methods of use thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted May 31, 2016·121 cites·21 claims
- 1197US8936942B2Polyethyleneglycol-modified lipid compounds and uses thereofHEYES JAMES·Filed 2010·Granted Jan 20, 2015·111 cites·39 claims
- 1297US8569256B2Cationic lipids and methods for the delivery of therapeutic agentsHEYES JAMES·Filed 2010·Granted Oct 29, 2013·485 cites·20 claims
- 1397US8466122B2Trialkyl cationic lipids and methods of use thereofHEYES JAMES·Filed 2011·Granted Jun 18, 2013·203 cites·18 claims
- 1497US7807815B2Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·68 cites·28 claims
- 1596US10561732B2Trialkyl cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2016·Granted Feb 18, 2020·13 cites·9 claims
- 1696US3956262ATriazenoimidazolesBEECHAM GROUP LTD·Filed 1974·Granted May 11, 1976·40 cites·5 claims
- 1795US11446383B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Sep 20, 2022·6 cites·17 claims
- 1895US11191849B2Compositions and methods for delivering messenger RNAARBUTUS BIOPHARMA CORP·Filed 2017·Granted Dec 7, 2021·10 cites·10 claims
- 1995US10077232B2Cyclic cationic lipids and methods of useHEYES JAMES·Filed 2011·Granted Sep 18, 2018·15 cites·30 claims
- 2095US8598333B2SiRNA silencing of genes expressed in cancerMACLACHLAN IAN·Filed 2007·Granted Dec 3, 2013·27 cites·8 claims
- 2194US9926560B2Lipid encapsulating interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Mar 27, 2018·6 cites·14 claims
- 2292US12043833B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 2392US2024316206A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2491US11427823B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Aug 30, 2022·5 cites·16 claims
- 2591US9126966B2Cationic lipids and methods of use thereofMARTIN ALAN·Filed 2012·Granted Sep 8, 2015·13 cites·41 claims
- 2690US8865675B2Compositions and methods for silencing apolipoprotein BHEYES JAMES·Filed 2011·Granted Oct 21, 2014·12 cites·46 claims
- 2788US2024100166A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 2884US11395854B2Trialkyl cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2020·Granted Jul 26, 2022·1 cites·14 claims
- 2982US2025099594A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 3082US2025179496A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 3181US2024245784A1Targeted nucleic acid conjugate compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 3280US9181545B2Lipid encapsulating interfering RNAMACLACHLAN IAN·Filed 2010·Granted Nov 10, 2015·1 cites·7 claims
- 3380US2023165973A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 3476US2023109183A1Trialkyl cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 3573US2020297870A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 3672US2018071397A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3772US2025281422A1Cationic lipids containing siliconARBUTUS BIOPHARMA CORP·Filed 2025·Application pending·0 cites
- 3869US12350383B2Cationic lipids containing siliconARBUTUS BIOPHARMA CORP·Filed 2019·Granted Jul 8, 2025·0 cites·9 claims
- 3967US2013122104A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsYAWORSKI ED·Filed 2012·Application pending·0 cites
- 4067US2025215042A1Mannose-targeted compositionsGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 4167US2019071669A1Lipid encapsulating interfering rnaARBUTUS PIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 4267US2020282060A1Novel cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 4366US2022160899A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4465US2025332112A1Ionizable cationic lipids for lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 4563US2024148663A1Peg lipids and lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 4663US2016151284A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4763US2024216545A1Mrna delivery constructs and methods of using the sameGENEVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 4861US11896672B2Targeted nucleic acid conjugate compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Feb 13, 2024·0 cites·11 claims
- 4961US2025114476A1Poly(alkyloxazoline)-lipid conjugates and lipid particles containing sameGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 5059US2014288146A1Novel trialkyl cationic lipids and methods of use thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James Heyes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →